Omphalophlebitis and osteomyelitis associated with Klebsiella septicemia in a premature foal.

This research investigates a case of a premature Standardbred colt diagnosed with Gram-negative neonatal septicemia that manifested symptoms like lethargy, weakness, and resultant conditions like pneumonia, omphalophlebitis, septic arthritis, and osteomyelitis. The afflictions were linked with risk factors like maternal uterine infection, premature birth and failure of the colostrum to transfer certain immunoglobulins. The treatment offered included antibiotics such as moxalactam disodium and cefadroxil. The study also discusses the effectiveness of cephalosporin antibiotics in treating Gram-negative sepsis.

Symptoms and Complications

• The foal, a premature Standardbred colt, showed several symptoms indicating a severe health concern. These included lethargy, weakness, inability to suckle, elevated respiratory rate, and inflamed mucous membranes.
• These symptoms escalated to more severe conditions such as pneumonia, inflammation of the umbilical cord (omphalophlebitis), joint inflammation due to infection (septic arthritis), and bone inflammation (osteomyelitis).

Risk Factors

• The study identified several risk factors that could have contributed to the foal’s ill health. These included a maternal uterine infection, premature delivery, abnormal parturition with early separation of fetal membranes, and a failure to transfer vital immunities from the mother to the foal via the colostrum.

Treatment

• The foal’s treatment included the administration of antibiotics, specifically moxalactam disodium and cefadroxil.
• The article also discusses the potential effectiveness of cephalosporin antibiotics in treating gram-negative bacteria responsible for neonatal septicemia.

Implications

• This case study highlights the risks and complications associated with neonatal septicemia in premature foals, emphasizing the importance of early treatment to prevent further complications.
• The article suggests further exploration into the use of cephalosporin antibiotics for the treatment of such conditions, potentially offering a new avenue for therapies in veterinary medicine.